Clinical Trial Update: MiSight 1 Day Safety Post-Approval Study [NA]

View source ↗

Summary

Ongoing post-approval safety study for CooperVision's MiSight 1 Day contact lenses in myopia control. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• MiSight 1-Day

Snippet

Sponsor: CooperVision, Inc. | Conditions: Myopia | NA | Status: RECRUITING